Rockwell Medical Inc (RMTI) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.005x

Based on the latest financial reports, Rockwell Medical Inc (RMTI) has a cash flow conversion efficiency ratio of -0.005x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-167.00K) by net assets ($35.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Rockwell Medical Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Rockwell Medical Inc - Cash Flow Conversion Efficiency Trend (1997–2025)

This chart illustrates how Rockwell Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Rockwell Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rockwell Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yeong Guan Energy Technology Group Co Ltd
TW:1589
-0.018x
Shenzhen Textile Holdings Co Ltd
SHE:200045
0.012x
Beamtree Holdings Ltd
AU:BMT
0.011x
ecotel communication ag
XETRA:E4C
0.191x
Inzi Display Co.Ltd
KQ:037330
0.157x
Eildon Capital Group
AU:EDC
0.319x
DongKoo Bio&Pharma Co. Ltd
KQ:006620
0.011x
CPI Aerostructures Inc
NYSE:CVU
0.008x

Annual Cash Flow Conversion Efficiency for Rockwell Medical Inc (1997–2025)

The table below shows the annual cash flow conversion efficiency of Rockwell Medical Inc from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see Rockwell Medical Inc (RMTI) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $36.98 Million $-659.00K -0.018x -113.82%
2024-12-31 $32.59 Million $4.20 Million 0.129x +129.17%
2023-12-31 $21.29 Million $-9.41 Million -0.442x +63.17%
2022-12-31 $14.11 Million $-16.93 Million -1.200x +90.93%
2021-12-31 $2.54 Million $-33.53 Million -13.228x -1424.96%
2020-12-31 $34.17 Million $-29.64 Million -0.867x +35.33%
2019-12-31 $20.32 Million $-27.25 Million -1.341x -79.17%
2018-12-31 $27.28 Million $-20.42 Million -0.749x -16.70%
2017-12-31 $32.91 Million $-21.11 Million -0.642x -172.81%
2016-12-31 $52.96 Million $-12.45 Million -0.235x +9.77%
2015-12-31 $62.32 Million $-16.24 Million -0.261x -520.51%
2014-12-31 $68.70 Million $4.26 Million 0.062x +100.07%
2013-12-31 $595.54K $-50.66 Million -85.074x -2856.37%
2012-12-31 $-9.96 Million $-30.75 Million 3.086x +622.23%
2011-12-31 $18.24 Million $-10.78 Million -0.591x -959.08%
2010-12-31 $30.54 Million $2.10 Million 0.069x +241.39%
2009-12-31 $29.32 Million $-1.43 Million -0.049x +86.53%
2008-12-31 $11.82 Million $-4.27 Million -0.361x -90.83%
2007-12-31 $17.96 Million $-3.40 Million -0.189x +53.49%
2006-12-31 $8.37 Million $-3.41 Million -0.407x -216.96%
2005-12-31 $3.84 Million $-493.52K -0.128x -142.79%
2004-12-31 $3.42 Million $1.03 Million 0.300x +322.10%
2003-12-31 $3.17 Million $225.42K 0.071x +119.41%
2002-12-31 $3.05 Million $-1.12 Million -0.366x -3.36%
2001-12-31 $2.60 Million $-920.02K -0.354x -104.25%
2000-12-31 $2.86 Million $-496.35K -0.173x +30.61%
1999-12-31 $3.60 Million $-900.00K -0.250x +50.00%
1998-12-31 $4.60 Million $-2.30 Million -0.500x +29.17%
1997-12-31 $1.70 Million $-1.20 Million -0.706x --

About Rockwell Medical Inc

NASDAQ:RMTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$26.73 Million
Market Cap Rank
#24203 Global
#5144 in USA
Share Price
$0.68
Change (1 day)
+5.48%
52-Week Range
$0.62 - $1.83
All Time High
$141.02
About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more